NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/21/2021
Back to search
Official data from USPTO
HYCOR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HYCOR
ST13
US500000077603484Class
1, 5, 9, 10
Filing
77603484
Registration
3958257
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
61
Latest update
04/21/2021
Trademark type
Word
Nice classes
1, 5, 9, 10
Filing date
10/29/2008
Registration date
05/10/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/21/2021
Last transaction
04/21/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
1998-00-00
First use in commerce
1998-00-00
Drawing code
4
Owner type
16
Owner location
GARDEN GROVE, CA
Examiner
FATHY, DOMINIC
Law office
L40
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
HYCOR BIOMEDICAL LLC
Hycor Biomedical, Inc.
Representatives
Gregory B. Coy Taft Stettinius & Hollister LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic reagents for scientificclinical laboratoryresearch use; assay kits composed of assays for scientificclinical laboratoryresearch purposes
Class 5
Autoimmune diagnostic test kits consisting primarily of reagentsbuffer concentratesantibodies for medical use for testing presence of autoimmune disease in humans; Quantitative Radioimmunoassay (RIA) Specific Immunoglobulin E (IgE) test kits consisting primarily of antibodies and reagents for testing presence of allergy in humans; diagnostic reagents for medical use; assay kits consisting primarily of assays for medical use for testing presence of allergy in humans
Class 9
Laboratory apparatusmicrotiter plate; microscopic slides and covers
Class 10
Medical immunoassays diagnostic tests and kits consisting of autoimmune testing apparatus used in blood and microbial testing for allergy and autoimmune disease diagnostic testing; Medical apparatusallergen discs for testing presence of allergy disease in humans; diagnostic apparatusautomated enzyme immunoassay immunoanalyzers for allergy and autoimmune disease diagnostic testing; medical disposable cupstubescaps for urine collection
Publications
History of USPTO decisions and trademark events.
61 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/21/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/21/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/21/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
01/07/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/10/2020
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03/15/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/28/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/28/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/28/2016
E815
TEAS SECTION 8 & 15 RECEIVED
10/19/2016
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/17/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/11/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/11/2016
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/10/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/25/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
05/10/2011
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/07/2011
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
04/06/2011
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/28/2011
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/14/2011
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/14/2011
IUAF
USE AMENDMENT FILED
02/23/2011
EISU
TEAS STATEMENT OF USE RECEIVED
02/23/2011
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/27/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/27/2011
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/26/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/26/2011
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/24/2010
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/16/2010
PUBO
PUBLISHED FOR OPPOSITION
06/29/2010
NPUB
NOTICE OF PUBLICATION
06/09/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/24/2010
ALIE
ASSIGNED TO LIE
05/24/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/14/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/13/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/13/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/13/2010
CNRT
NON-FINAL ACTION MAILED
03/31/2010
CNRT
NON-FINAL ACTION WRITTEN
03/30/2010
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
03/23/2010
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
03/19/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/09/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/08/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/08/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/08/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/05/2010
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/26/2010
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/26/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/09/2009
GNRT
NON-FINAL ACTION E-MAILED
09/09/2009
CNRT
NON-FINAL ACTION WRITTEN
09/09/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/20/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/20/2009
ALIE
ASSIGNED TO LIE
08/20/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/04/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/05/2009
GNRT
NON-FINAL ACTION E-MAILED
02/05/2009
CNRT
NON-FINAL ACTION WRITTEN
02/05/2009
DOCK
ASSIGNED TO EXAMINER
01/29/2009
NWAP
NEW APPLICATION ENTERED
11/03/2008
Continuous trademark protection
Get notified about every new filing that threatens HYCOR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.